Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Participants receive a personalized GLP-1 coaching plan and focused educational content on medication and symptom management, developed by our medication management coaches and other clinical experts
Segerdahl, A
The market encompassing weight loss treatments utilizing glucagon-like peptide-1 (GLP-1) agonists is projected to experience swift expansion moving forward, reaching an estimated value of $28.3 billion by the year 2029, reflecting a compound annual growth rate (CAGR) of 16.3%
How does this hybrid approach help
Glucagon-like peptide 1 (GLP-1) receptor agonists, commonly referred to as GLP-1 drugs, are widely recognized for their use in managing type 2 diabetes and supporting weight loss
